Brief: Eton Pharmaceuticals Closes Acquisition Of Increlex® (Mecasermin Injection)
20/12/2024 11:50
Dec 20 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS CLOSES ACQUISITION OF INCRELEX®
(MECASERMIN
INJECTION)
Source text: ID:nGNX4HCb6f
Further company coverage: ETON.O
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer